A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
Applying to University of Chicago Medical Center /ID# 270517 · Chicago, Illinois
Answer a few short questions to share with the research team.